How can India contain the second wave?
When do you think the second wave is likely to peak? And when we see such a peak, what do you think will be the number of daily cases? Gautam…
Category: Coronavirus
In a major shift, India fast-tracks restricted use approval for vaccines developed in other countries
The vaccines that would be eligible for the fast-track approval will include those that have been granted an EUA by the US Food and Drug Administration (FDA), European Medicines Agency…
COVID-19: Protection against reinfection may last only for months
The first serosurvey was carried out in August-September 2020 and the six-month follow-up was carried out in end-January to February 2021. Widespread asymptomatic infection by mid-September when the daily cases…
India will add four million more cases by May 1, says Giridhara Babu
The increase in daily cases has been very steep — from over 12,200 cases on March 1 to over 1,26,000 on April 7. The doubling time has reduced from 504…
180 deaths following COVID-19 vaccination reported in India
In all, 492 severe and serious AEFI have been classified by the AEFI Secretariat of the immunisation technical support unit (ITSU) at the Health Ministry. Classification has been completed for…
Health Ministry reveals the names of SEC members for vaccine approval
Names of the ten members Dr. Varsha Gupta, Professor, Department of Microbiology, Government Medical College Hospital, Chandigarh; 2) Dr. Archana Thakur, Medical Director, Professor and HOD (Microbiology), G.B. Pant Hospital,…
What is driving the second wave in India?
The rate of increase in cases in India during March has been faster than at any other time during the pandemic, which is also reflected in the modelling studies by…
SEC allows Bharat Biotech to unblind all participants above 45 years
The Subject Expert Committee (SEC) has permitted Bharat Biotech to unblind all phase-3 trial participants above 45 years and offer the vaccine to those who received a placebo. The reason: vaccines (including Covaxin) are already available under the immunisation programme, and therefore all the eligible age groups should be unblinded for vaccination.
